Outsourced Manufacturing / A Swiss Specialty
Unknown to some, Switzerland meanwhile remains both influential and relevant in global pharma circles not just for…
Louis Haynes |
Editor
Louis is the Senior Analyst and Editor-in-Chief. Having directed pharmaceuticals & life science projects across 4 continents, he has published over 30 country reports as well as produced analytical studies on trends in blockchain, Pharma M&A and biotechnology. He has a professional background in consultancy and international business and possesses an MPhil from the University of Oxford and more...
Articles: Louis Haynes
Oncology / Switzerland: Fresh Tactics in the War on Cancer
With cancer now causing one in eight deaths globally and, in Europe, even outpacing serious cardiovascular…
Internationalization / France's Mid-Cap Pharma Champions Look to Global Markets
With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma…
InFocus / Cannabis
PharmaBoardroom’s new InFocus section examines the fast-growing and lucrative global medical cannabis market,…
Company Profile / Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape,…
Philanthropy / A Boost for Spain’s Out-of-Date Hospital Equipment
Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no…
Profile / Aspen Spain: Thriving on Change
The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia…
Five Emerging Trends in Medical Cannabis
Five of the key emerging trends in the booming global medical cannabis and cannabinoid medicine industries.…
CEO Profile / Servier’s Olivier Laureau: Change Instigator
Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world…
Swiss Mid-Caps and Minnows: At the Vanguard of Creativity
In view of the manifold hurdles encountered when attempting to raise capital, Switzerland’s medium capitalized…
Pierre Fabre: Medicalization, Convergence & the Rise of…
Iconic French skincare specialist, Pierre Fabre has been enjoying a hot streak of late, with its dermo-cosmetics…
5 Key Trends in Orphan Drugs & Rare Diseases
Long regarded as a neglected backwater within the drug discovery landscape and the preserve of only a handful of…